Croda's profits decline on COVID-19 impacts, higher M&A costs
11:27 AM | March 2, 2021 | Sotirios Frantzanas
Company's 2020 sales were up with life sciences business posting strong revenue, earnings growth.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.